An RCT on the effect of the FADS2 SNP on left ventricularremodeling after acute myocardial infarction (AMI) demonstrated that six monthsof high doses of ω-3 PUFAs after an AMI resulted in a significantattenuation of adverse left ventricular remodeling, noninfective myocardialfibrosis, and amelioration of the FADS2 rs1535GG-imposedhyperinflammatory response [51]. The gene discussed is FADS2; the disease is myocardial infarction.